veklury
gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
rigmin 9,5 mg/24 timer depotplastre
sandoz a/s - rivastigmin - depotplastre - 9,5 mg/24 timer
atorvastatin "xiromed" 20 mg filmovertrukne tabletter
medical valley invest ab - atorvastatincalcium (trihydrat) - filmovertrukne tabletter - 20 mg
atorvastatin "xiromed" 40 mg filmovertrukne tabletter
medical valley invest ab - atorvastatincalcium (trihydrat) - filmovertrukne tabletter - 40 mg
atorvastatin "xiromed" 80 mg filmovertrukne tabletter
medical valley invest ab - atorvastatincalcium (trihydrat) - filmovertrukne tabletter - 80 mg
mirtazapin "bluefish" 30 mg smeltetabletter
bluefish pharmaceuticals ab - mirtazapin - smeltetabletter - 30 mg
mirtazapin "bluefish" 45 mg smeltetabletter
bluefish pharmaceuticals ab - mirtazapin - smeltetabletter - 45 mg
laddok te suspensionskoncentrat
basf a/s - bentazon, terbuthylazin - suspensionskoncentrat - 200 g/l bentazon ; 200 g/l terbuthylazin
lixacol 400 mg enterotabletter
orifarm a/s - mesalazin - enterotabletter - 400 mg
aloxi
helsinn birex pharmaceuticals ltd. - palonosetronhydrochlorid - vomiting; cancer - antiemetika og antinauseants, , serotonin (5ht3) antagonister - aloxi er angivet i voksne til forebyggelse af akut kvalme og opkastning forbundet med meget emetogenic kemoterapi mod kræft,forebyggelse af kvalme og opkastning i forbindelse med moderat emetogenic kræft kemoterapi. aloxi er angivet i pædiatriske patienter, der 1 måned, og ældre, for:forebyggelse af akut kvalme og opkastning forbundet med meget emetogenic kemoterapi og forebyggelse af kvalme og opkastning i forbindelse med moderat emetogenic kræft kemoterapi.